It was almost like a forced speech while someone backstage had a gun pointed at the person on the stage making the speech. No slip ups allowed or a breach could have been said to have occurred. Pfizer still have not tossed in the $3 million as yet so TK is playing the game as the rules are written. RAP "expects" to receive the Pfizer $3 million plus $1 million in Q4. Him saying that the company would do well without Pfizer is not betraying the Pfizer agreement it is simply stating a fact that is shared by us all. Pfizer will be watching carefully the remarks from the BOD and TK to see that there has been no legal breach of the agreement to recommend the scheme to RAP shareholders. One could draw a long bow and almost imagine Pfizer reneging on the non exclusive license and R&D deal if the NO vote is carried and they can (if they decided to out of spite for being voted against by SH) Show cause that the arrangement with RAP re the deal being in the best interests of SH was not adhered to in their eyes Fair value assessment is the next hurdle to jump...after that little gem may come a left field offer or two for a partnership type deal (equity plus access to markets plus maybe royalties on top. Now Coviu is back in town with ResApDx and has a very decent RAP promo, recommendation and directions for use on their website now. Coviu also say they have had >6.5 million telehealth calls so far.
RAP Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
